Myeloid cells also appear to support immune evasion in PDAC through EGFR/MAPK-dependent regulation of PD-L1 expression on tumor cells, since depletion of myeloid cells prevented KrasG12D-driven PDAC initiation and restored CD8+ T cell anti-tumor immunity [210]. The gene discussed is EGFR; the disease is neoplasm.